Hennion & Walsh Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,265
Closed -$550K 932
2025
Q1
$550K Sell
1,265
-101
-7% -$40.5K 0.02% 609
2024
Q4
$504K Sell
1,366
-1,421
-51% -$595K 0.02% 618
2024
Q3
$1.45M Sell
2,787
-1,049
-27% -$560K 0.07% 363
2024
Q2
$2.08M Sell
3,836
-2,300
-37% -$1.22M 0.11% 243
2024
Q1
$3.18M Sell
6,136
-1,319
-18% -$656K 0.17% 159
2023
Q4
$3.52M Sell
7,455
-4,002
-35% -$1.85M 0.2% 131
2023
Q3
$4.99M Sell
11,457
-2,942
-20% -$1.33M 0.32% 62
2023
Q2
$6.4M Sell
14,399
-1,364
-9% -$629K 0.38% 49
2023
Q1
$7.25M Buy
15,763
+472
+3% +$225K 0.44% 45
2022
Q4
$7.84M Sell
15,291
-1,519
-9% -$771K 0.48% 41
2022
Q3
$7.64M Buy
16,810
+1,890
+13% +$904K 0.5% 43
2022
Q2
$7.2M Buy
14,920
+2,297
+18% +$1.14M 0.45% 49
2022
Q1
$6.2M Buy
12,623
+784
+7% +$358K 0.33% 73
2021
Q4
$5.49M Buy
11,839
+4,084
+53% +$1.72M 0.27% 100
2021
Q3
$2.89M Buy
7,755
+1,466
+23% +$557K 0.15% 195
2021
Q2
$2.4M Buy
6,289
+2,832
+82% +$1.08M 0.13% 216
2021
Q1
$1.24M Buy
+3,457
New +$1.11M 0.07% 313

Other funds holding ELV

Hennion & Walsh Asset Management's ELV Position: Q2 2025 in Review

Hennion & Walsh Asset Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,265 shares — an estimated $550K sold.

Hennion & Walsh Asset Management first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $7.84M in Q4 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Hennion & Walsh Asset Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 1,265 Elevance Health shares in Q2 2025, an estimated $550K.
  • Hennion & Walsh Asset Management first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
  • Hennion & Walsh Asset Management's Elevance Health position peaked at $7.84M in Q4 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.